Sort by

Send to

Choose Destination

Links from PubMed

Items: 16


Leinamycin E1 acting as an anticancer prodrug activated by reactive oxygen species.

Huang SX, Yun BS, Ma M, Basu HS, Church DR, Ingenhorst G, Huang Y, Yang D, Lohman JR, Tang GL, Ju J, Liu T, Wilding G, Shen B.

Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8278-83. doi: 10.1073/pnas.1506761112. Epub 2015 Jun 8.


The Use of Chemical-Chemical Interaction and Chemical Structure to Identify New Candidate Chemicals Related to Lung Cancer.

Chen L, Yang J, Zheng M, Kong X, Huang T, Cai YD.

PLoS One. 2015 Jun 5;10(6):e0128696. doi: 10.1371/journal.pone.0128696. eCollection 2015.


Expression of spermidine/spermine N(1) -acetyl transferase (SSAT) in human prostate tissues is related to prostate cancer progression and metastasis.

Huang W, Eickhoff JC, Mehraein-Ghomi F, Church DR, Wilding G, Basu HS.

Prostate. 2015 Aug 1;75(11):1150-9. doi: 10.1002/pros.22996. Epub 2015 Apr 20.


STAMP2 increases oxidative stress and is critical for prostate cancer.

Jin Y, Wang L, Qu S, Sheng X, Kristian A, Mælandsmo GM, Pällmann N, Yuca E, Tekedereli I, Gorgulu K, Alpay N, Sood A, Lopez-Berestein G, Fazli L, Rennie P, Risberg B, Wæhre H, Danielsen HE, Ozpolat B, Saatcioglu F.

EMBO Mol Med. 2015 Feb 13;7(3):315-31. doi: 10.15252/emmm.201404181.


Increased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase.

Chaturvedi R, de Sablet T, Asim M, Piazuelo MB, Barry DP, Verriere TG, Sierra JC, Hardbower DM, Delgado AG, Schneider BG, Israel DA, Romero-Gallo J, Nagy TA, Morgan DR, Murray-Stewart T, Bravo LE, Peek RM Jr, Fox JG, Woster PM, Casero RA Jr, Correa P, Wilson KT.

Oncogene. 2015 Jun;34(26):3429-40. doi: 10.1038/onc.2014.273. Epub 2014 Sep 1.


A microfluidic coculture and multiphoton FAD analysis assay provides insight into the influence of the bone microenvironment on prostate cancer cells.

Bischel LL, Casavant BP, Young PA, Eliceiri KW, Basu HS, Beebe DJ.

Integr Biol (Camb). 2014 Jun;6(6):627-35. doi: 10.1039/c3ib40240a.


Targeting androgen receptor and JunD interaction for prevention of prostate cancer progression.

Mehraein-Ghomi F, Kegel SJ, Church DR, Schmidt JS, Reuter QR, Saphner EL, Basu HS, Wilding G.

Prostate. 2014 May;74(7):792-803. doi: 10.1002/pros.22800. Epub 2014 Mar 20.


Arginase 2 deficiency reduces hyperoxia-mediated retinal neurodegeneration through the regulation of polyamine metabolism.

Narayanan SP, Xu Z, Putluri N, Sreekumar A, Lemtalsi T, Caldwell RW, Caldwell RB.

Cell Death Dis. 2014 Feb 20;5:e1075. doi: 10.1038/cddis.2014.23.


Redox-mediated and ionizing-radiation-induced inflammatory mediators in prostate cancer development and treatment.

Miao L, Holley AK, Zhao Y, St Clair WH, St Clair DK.

Antioxid Redox Signal. 2014 Mar 20;20(9):1481-500. doi: 10.1089/ars.2013.5637. Epub 2014 Jan 22. Review.


Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis.

Goodwin AC, Destefano Shields CE, Wu S, Huso DL, Wu X, Murray-Stewart TR, Hacker-Prietz A, Rabizadeh S, Woster PM, Sears CL, Casero RA Jr.

Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15354-9. doi: 10.1073/pnas.1010203108. Epub 2011 Aug 29.


The curcumin analog ca27 down-regulates androgen receptor through an oxidative stress mediated mechanism in human prostate cancer cells.

Fajardo AM, MacKenzie DA, Ji M, Deck LM, Vander Jagt DL, Thompson TA, Bisoffi M.

Prostate. 2012 May 1;72(6):612-25. doi: 10.1002/pros.21464. Epub 2011 Jul 27.


Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer.

Barocas DA, Motley S, Cookson MS, Chang SS, Penson DF, Dai Q, Milne G, Roberts LJ 2nd, Morrow J, Concepcion RS, Smith JA Jr, Fowke JH.

J Urol. 2011 Jun;185(6):2102-7. doi: 10.1016/j.juro.2011.02.020. Epub 2011 Apr 15.


Cys-141 glutathionylation of human p53: Studies using specific polyclonal antibodies in cancer samples and cell lines.

Yusuf MA, Chuang T, Bhat GJ, Srivenugopal KS.

Free Radic Biol Med. 2010 Sep 1;49(5):908-17. doi: 10.1016/j.freeradbiomed.2010.06.020. Epub 2010 Jun 25.


Pretreatment with anti-oxidants sensitizes oxidatively stressed human cancer cells to growth inhibitory effect of suberoylanilide hydroxamic acid (SAHA).

Basu HS, Mahlum A, Mehraein-Ghomi F, Kegel SJ, Guo S, Peters NR, Wilding G.

Cancer Chemother Pharmacol. 2011 Mar;67(3):705-15. doi: 10.1007/s00280-010-1364-3. Epub 2010 May 30.


Androgen receptor requires JunD as a coactivator to switch on an oxidative stress generation pathway in prostate cancer cells.

Mehraein-Ghomi F, Basu HS, Church DR, Hoffmann FM, Wilding G.

Cancer Res. 2010 Jun 1;70(11):4560-8. doi: 10.1158/0008-5472.CAN-09-3596. Epub 2010 May 11.

Items per page

Supplemental Content

Write to the Help Desk